Software Engineering plays a key role in insitro’s approach to rethinking drug development. Our team is responsible for the software platform at insitro, which covers everything from providing orchestration and workflow software for our automated lab (LIMS, data review/visualization), data pipelines for ingesting data from pharma and research collaborators, bioinformatic pipelines for our genomic datasets, and APIs and tooling for our data science and machine learning teams.
As a Software Engineering Manager of Scientific Pipelines, you will work closely with a cross-functional team of scientists, bioengineers, and data scientists to identify areas where software engineering can make a difference. You will grow and mentor a team of software engineers to design, implement, and deploy software systems supporting scientific pipelines across broad domains: bioinformatics (single cell RNAseq, variant calling, GWAS, postGWAS), cheminformatic, and image processing. As part of an early engineering organization, you will also be defining the work and collaboration norms of the team, such as approaches to Software Development Life Cycle, collaboration in cross-functional projects, defining team vision, goals, and roadmap.
You will be joining a biotech startup that has long-term stability due to significant funding, providing many opportunities for meaningful impact. You will work closely with a very talented team, learn a broad range of skills, and help shape insitro’s culture, strategic direction, and outcomes. Join us, and help make a difference to patients!
Benefits at insitro
insitro is a drug discovery and development company using machine learning and data generation at scale to transform the way that drugs are discovered and delivered to patients. We rely on human genetic cohorts, human-derived cellular disease models, and high-throughput biology and chemistry to identify coherent patient segments, actionable therapeutic targets, and new or existing chemical matter. The goal is to deliver predictive insights to improve the probability of success and reduce the number of costly dead ends along the R&D journey. The company has established enabling collaborations with Gilead in NASH and Bristol Myers Squibb in ALS and is building a pipeline of wholly owned and partnered medicines leveraging its unique insights on patient biomarkers, targets, and molecules. insitro is located in South San Francisco, CA and has raised over $600M from top tech, biotech, and crossover investors since formation in 2018. For more information on insitro, please visit the company’s website at www.insitro.com.
Your application was submitted successfully.